Glecirasib

Synopsis, Chemistry

DEVELOPMENTS

4 Drug(s) in Development

4 Drug(s) in Development

DIGITAL CONTENT

1 News

1 News

Product Search

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

JDMFs Filed

EU WC

Listed Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

FDF Market Place

EXCIPIENTS

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

Other Listed Suppliers

SERVICES

Also known as: Glecirasib, Kras g12c inhibitor 62, Glecirasib [inn], Up75wh4qkm, Schembl23830094, Ex-a8185q

Molecular Formula

C₃₁H₂₆ClF₄N₇O₂

Molecular Weight

640.0 g/mol

InChI Key

QRRJEUIQLZNPIO-UHFFFAOYSA-N

FDA UNII

UP75WH4QKM

Glecirasib is an orally available inhibitor of the oncogenic KRAS substitution mutation, G12C, with potential antineoplastic activity. Upon oral administration, glecirasib selectively targets, binds to and inhibits the activity of the KRAS G12C mutant, thereby inhibiting KRAS G12C mutant-dependent signaling. KRAS, a member of the RAS family of oncogenes, serves an important role in cell signaling, division and differentiation. Mutations of KRAS may induce constitutive signal transduction leading to tumor cell growth, proliferation, invasion, and metastasis.

1 2D Structure

Glecirasib

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

7-(2-amino-3,4,5,6-tetrafluorophenyl)-6-chloro-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-2-oxo-4-(4-prop-2-enoylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile

2.1.2 InChI

InChI=1S/C31H26ClF4N7O2/c1-5-19(44)41-8-10-42(11-9-41)29-16-12-18(32)27(20-21(33)22(34)23(35)24(36)25(20)38)40-30(16)43(31(45)17(29)13-37)28-15(4)6-7-39-26(28)14(2)3/h5-7,12,14H,1,8-11,38H2,2-4H3

2.1.3 InChI Key

QRRJEUIQLZNPIO-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=C(C(=NC=C1)C(C)C)N2C3=NC(=C(C=C3C(=C(C2=O)C#N)N4CCN(CC4)C(=O)C=C)Cl)C5=C(C(=C(C(=C5F)F)F)F)N

2.2 Other Identifiers

2.2.1 UNII

UP75WH4QKM

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Glecirasib

2. Kras G12c Inhibitor 62

3. Glecirasib [inn]

4. Up75wh4qkm

5. Schembl23830094

6. Ex-a8185q

7. Hy-143589

8. Hy-157067

9. Cs-0373885

10. Cs-0904896

11. 2657613-87-9

12. 2658588-10-2

2.4 Create Date

2021-12-03

3 Chemical and Physical Properties

Molecular Formula	C₃₁H₂₆ClF₄N₇O₂
Molecular Weight	640.0 g/mol
XLogP3	4.4
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	11
Rotatable Bond Count	5
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	119
Heavy Atom Count	45
Formal Charge	0
Complexity	1240
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1